Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis

Arechabala, María Cecilia; Catoni, María Isabel; Claro, Juan Carlos; Rojas, Noelia Pilar; Rubio, Miriam; Calvo, Mario; Letelier, Luz María

doi:10.1002/14651858.cd010597.pub2

Cited by 34 publications

(33 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…63 The effectiveness of citrate and antimicrobial lock solutions in decreasing the rate of catheter-related infections remains unclear and is the subject of ongoing investigation. 64 In addition to the risk of bleeding from an inadvertent bolus of the locking solution with catheter access, all catheters will leak locking solution for the first 30 min with some systemic effects occurring for up to four hours. Heparin carries a further risk of heparin-induced thrombocytopenia, and citrate risks a metallic taste and perioral and/or digital paresthesia.…”

Section: Timing Of Rrtmentioning

confidence: 99%

Renal replacement therapy: a practical update

Alvarez

Chrusch

Hulme

et al. 2019

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

Acute kidney injury (AKI) is defined as an abrupt decrease in kidney function, with the most severe form requiring some method of renal replacement therapy (RRT). The use of RRT is required in 5-10% of critically ill patients who develop severe AKI. Renal replacement therapy can be provided as either intermittent hemodialysis or one of the various modes of continuous renal replacement therapy (CRRT), with CRRT potentially conferring an advantage with respect to renal recovery and dialysis independence. There is no difference in mortality when comparing low (\ 25 mLÁkg -1 Áhr -1 ) vs high ([ 40 mLÁkg -1 Áhr -1 ) RRT dosing. Continuous renal replacement therapy may be run in different modes of increasing complexity depending on a given patient's clinical needs. Regional citrate anticoagulation is recommended as the therapy of choice for the majority of critically ill patients requiring CRRT.

show abstract

Section: Timing Of Rrtmentioning

confidence: 99%

Renal replacement therapy: a practical update

Alvarez

Chrusch

Hulme

et al. 2019

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

show abstract

“…Second, make better use and improve outcome of tCVC or implanted venous access port devices by implementing strict rules of handling and generalisation of catheter locking solutions [157].…”

Section: Va Future Outlookmentioning

confidence: 99%

Vascular Access Management for Haemodialysis: A Value-Based Approach from NephroCare Experience

Canaud¹,

Ponce²,

Parisotto³

et al. 2019

Vascular Access Surgery - Tips and Tricks

View full text Add to dashboard Cite

A good functioning vascular access (VA) is a prerequisite to obtain a successful dialysis treatment. This chapter reviews VA management in advanced chronic kidney disease (CKD) patients drawn from the experience of a large network dialysis care provider with the following sections: overview on VA management in advanced CKD that follows patient pathway and patient profile, current practice patterns in line with best clinical practices; VA creation addressing crucial themes: when and what type of VA to construct, how to assess patient pre-emptively, how to proceed for the construction and monitoring to prevent early failures and complications; VA management with particular focus on clinical monitoring, surveillance and interventional procedures required to preserve patency and functionality of VA; the often-forgotten patient perspective is VA usage. What information to share, how to proceed for preventing pain, and fears related with VA needling? What should patients know about their VA and how to manage in daily life? Competences, skills and responsibilities of nursing staff when using and managing VA; and future of VA in terms of innovative concept for creating and maintaining VA conduits in dialysis patients.

show abstract

“…The ESMO guidelines (2015) [18] and the recent literature [19], provide for the use of ALT in prevention for long-term infections associated with central venous catheters (CLABSI) in cancer patients. Even if several evidences support the use of ALT in seriously ill patients such as patients in need of palliative care, the effectiveness in patients in need of hemodialysis is still unclear [20]. Despite the elaboration of all these clinical practice protocols or guidelines, the most appropriate lock solution for central venous access devices is still to be defined [19].…”

Section: Introductionmentioning

confidence: 99%

Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review Protocol

Alfieri

Franco

Passavanti

et al. 2020

MPs

View full text Add to dashboard Cite

Our objective is to review the scientific literature on the use of antimicrobial lock therapy (ALT). To achieve this result, our scoping review will address the following seven key questions: (1) Who are the patients who will benefit from this technique? (2) What are the techniques utilized? (3) What are the settings in which the technique is performed? (4) When the technique is performed? (5) Why the technique is performed? (6) How the technique is performed? (7) In how much amount, of such technique performed? This review considers all studies published in full and in peer-reviewed journals, with no restrictions on language, on the year of publication and age of the participants. Both randomized controlled trials and observational studies will be included. This scoping review has been planned on a five-stage framework: 1. Identifying the review question; 2. identifying relevant studies; 3. study selection; 4. charting the data; 5. collating, summarizing, and reporting the results. It is conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Guidelines. The databases utilized will include MEDLINE via PubMed, EMBASE and Cochrane Central Register of Controlled Trials and Grey Literature. SCOPING REVIEW REGISTRATION: Open Science Framework https://osf.io/vphwm/.

show abstract

Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis

Abstract: Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.

Cited by 34 publications

References 78 publications

Renal replacement therapy: a practical update

Renal replacement therapy: a practical update

Vascular Access Management for Haemodialysis: A Value-Based Approach from NephroCare Experience

Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review Protocol

Contact Info

Product

Resources

About